Philips' ThoraVision CR wins FDA nod

Article

The Food and Drug Administrationcleared Philips' ThoraVision computed radiography system lastmonth, setting the stage for a pitched battle between the Dutchvendor and Fuji Medical Systems, which has dominated CR for years. Philips introduced

The Food and Drug Administrationcleared Philips' ThoraVision computed radiography system lastmonth, setting the stage for a pitched battle between the Dutchvendor and Fuji Medical Systems, which has dominated CR for years.

Philips introduced ThoraVision at last year's European Congressof Radiology meeting in Vienna (SCAN 9/16/93). The selenium-baseddigital chest system is the first non-phosphor CR system offeredby a major multimodality imaging systems vendor.

Philips spent a decade developing the selenium detector technologyused in ThoraVision. Selenium was chosen because of its broaddynamic range and wide tolerance to over- or underexposure, accordingto the company. Philips sees lung imaging as one of the largestapplications for the system. Other thoracic objects, such as theheart, pericardium, trachea and blood vessels, can also be imaged.

Fuji has built a commanding lead in CR due to its strong patentposition covering phosphor-based imaging. The company has notbeen resting on its laurels, however. It has set its product developmenteffort at a blistering pace in preparation for the entry of competitorslike Philips into the CR market, an event that will become morelikely with the expiration of Fuji's core patent in 1996.

At last year's Radiological Society of North America meeting,Fuji debuted FCR 9000, a workhorse CR reader that is the platformfor the company's works-in-progress dynamic range control (DRC)technology (SCAN 2/2/94). Fuji also unveiled AC-3, a low-costCR reader capable of processing 70 imaging plates per hour.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.